nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Loss of consciousness—Docetaxel—ovarian cancer	0.000822	0.000822	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000821	0.000821	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Epirubicin—ovarian cancer	0.000817	0.000817	CcSEcCtD
Gadoversetamide—Cough—Docetaxel—ovarian cancer	0.000816	0.000816	CcSEcCtD
Gadoversetamide—Insomnia—Paclitaxel—ovarian cancer	0.000815	0.000815	CcSEcCtD
Gadoversetamide—Pneumonia—Epirubicin—ovarian cancer	0.000812	0.000812	CcSEcCtD
Gadoversetamide—Convulsion—Docetaxel—ovarian cancer	0.00081	0.00081	CcSEcCtD
Gadoversetamide—Paraesthesia—Paclitaxel—ovarian cancer	0.000809	0.000809	CcSEcCtD
Gadoversetamide—Hypertension—Docetaxel—ovarian cancer	0.000808	0.000808	CcSEcCtD
Gadoversetamide—Dyspnoea—Paclitaxel—ovarian cancer	0.000803	0.000803	CcSEcCtD
Gadoversetamide—Somnolence—Paclitaxel—ovarian cancer	0.000801	0.000801	CcSEcCtD
Gadoversetamide—Myalgia—Docetaxel—ovarian cancer	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Chest pain—Docetaxel—ovarian cancer	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Arthralgia—Docetaxel—ovarian cancer	0.000796	0.000796	CcSEcCtD
Gadoversetamide—Nausea—Vinorelbine—ovarian cancer	0.000795	0.000795	CcSEcCtD
Gadoversetamide—Dyspepsia—Paclitaxel—ovarian cancer	0.000793	0.000793	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000791	0.000791	CcSEcCtD
Gadoversetamide—Urinary tract infection—Epirubicin—ovarian cancer	0.000785	0.000785	CcSEcCtD
Gadoversetamide—Conjunctivitis—Epirubicin—ovarian cancer	0.000785	0.000785	CcSEcCtD
Gadoversetamide—Dysuria—Doxorubicin—ovarian cancer	0.000783	0.000783	CcSEcCtD
Gadoversetamide—Decreased appetite—Paclitaxel—ovarian cancer	0.000783	0.000783	CcSEcCtD
Gadoversetamide—Dry mouth—Docetaxel—ovarian cancer	0.000779	0.000779	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000778	0.000778	CcSEcCtD
Gadoversetamide—Fatigue—Paclitaxel—ovarian cancer	0.000776	0.000776	CcSEcCtD
Gadoversetamide—Pain—Paclitaxel—ovarian cancer	0.00077	0.00077	CcSEcCtD
Gadoversetamide—Constipation—Paclitaxel—ovarian cancer	0.00077	0.00077	CcSEcCtD
Gadoversetamide—Haematuria—Epirubicin—ovarian cancer	0.00077	0.00077	CcSEcCtD
Gadoversetamide—Confusional state—Docetaxel—ovarian cancer	0.00077	0.00077	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000763	0.000763	CcSEcCtD
Gadoversetamide—Oedema—Docetaxel—ovarian cancer	0.000763	0.000763	CcSEcCtD
Gadoversetamide—Epistaxis—Epirubicin—ovarian cancer	0.000761	0.000761	CcSEcCtD
Gadoversetamide—Sinusitis—Epirubicin—ovarian cancer	0.000757	0.000757	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000756	0.000756	CcSEcCtD
Gadoversetamide—Pneumonia—Doxorubicin—ovarian cancer	0.000751	0.000751	CcSEcCtD
Gadoversetamide—Shock—Docetaxel—ovarian cancer	0.000751	0.000751	CcSEcCtD
Gadoversetamide—Nervous system disorder—Docetaxel—ovarian cancer	0.000749	0.000749	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000747	0.000747	CcSEcCtD
Gadoversetamide—Tachycardia—Docetaxel—ovarian cancer	0.000745	0.000745	CcSEcCtD
Gadoversetamide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000742	0.000742	CcSEcCtD
Gadoversetamide—Skin disorder—Docetaxel—ovarian cancer	0.000741	0.000741	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000736	0.000736	CcSEcCtD
Gadoversetamide—Haemoglobin—Epirubicin—ovarian cancer	0.000728	0.000728	CcSEcCtD
Gadoversetamide—Anorexia—Docetaxel—ovarian cancer	0.000728	0.000728	CcSEcCtD
Gadoversetamide—Rhinitis—Epirubicin—ovarian cancer	0.000727	0.000727	CcSEcCtD
Gadoversetamide—Urinary tract infection—Doxorubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Gadoversetamide—Conjunctivitis—Doxorubicin—ovarian cancer	0.000726	0.000726	CcSEcCtD
Gadoversetamide—Haemorrhage—Epirubicin—ovarian cancer	0.000725	0.000725	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Epirubicin—ovarian cancer	0.000721	0.000721	CcSEcCtD
Gadoversetamide—Pharyngitis—Epirubicin—ovarian cancer	0.000719	0.000719	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000716	0.000716	CcSEcCtD
Gadoversetamide—Urticaria—Paclitaxel—ovarian cancer	0.000715	0.000715	CcSEcCtD
Gadoversetamide—Oedema peripheral—Epirubicin—ovarian cancer	0.000714	0.000714	CcSEcCtD
Gadoversetamide—Hypotension—Docetaxel—ovarian cancer	0.000713	0.000713	CcSEcCtD
Gadoversetamide—Haematuria—Doxorubicin—ovarian cancer	0.000712	0.000712	CcSEcCtD
Gadoversetamide—Abdominal pain—Paclitaxel—ovarian cancer	0.000712	0.000712	CcSEcCtD
Gadoversetamide—Body temperature increased—Paclitaxel—ovarian cancer	0.000712	0.000712	CcSEcCtD
Gadoversetamide—Urethral disorder—Epirubicin—ovarian cancer	0.00071	0.00071	CcSEcCtD
Gadoversetamide—Epistaxis—Doxorubicin—ovarian cancer	0.000705	0.000705	CcSEcCtD
Gadoversetamide—Sinusitis—Doxorubicin—ovarian cancer	0.000701	0.000701	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000695	0.000695	CcSEcCtD
Gadoversetamide—Insomnia—Docetaxel—ovarian cancer	0.00069	0.00069	CcSEcCtD
Gadoversetamide—Paraesthesia—Docetaxel—ovarian cancer	0.000685	0.000685	CcSEcCtD
Gadoversetamide—Erythema multiforme—Epirubicin—ovarian cancer	0.000685	0.000685	CcSEcCtD
Gadoversetamide—Dyspnoea—Docetaxel—ovarian cancer	0.000681	0.000681	CcSEcCtD
Gadoversetamide—Somnolence—Docetaxel—ovarian cancer	0.000679	0.000679	CcSEcCtD
Gadoversetamide—Eye disorder—Epirubicin—ovarian cancer	0.000677	0.000677	CcSEcCtD
Gadoversetamide—Tinnitus—Epirubicin—ovarian cancer	0.000676	0.000676	CcSEcCtD
Gadoversetamide—Haemoglobin—Doxorubicin—ovarian cancer	0.000674	0.000674	CcSEcCtD
Gadoversetamide—Cardiac disorder—Epirubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Gadoversetamide—Flushing—Epirubicin—ovarian cancer	0.000673	0.000673	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—ovarian cancer	0.000672	0.000672	CcSEcCtD
Gadoversetamide—Dyspepsia—Docetaxel—ovarian cancer	0.000672	0.000672	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—ovarian cancer	0.000671	0.000671	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000667	0.000667	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—ovarian cancer	0.000666	0.000666	CcSEcCtD
Gadoversetamide—Decreased appetite—Docetaxel—ovarian cancer	0.000664	0.000664	CcSEcCtD
Gadoversetamide—Hypersensitivity—Paclitaxel—ovarian cancer	0.000664	0.000664	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000662	0.000662	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—ovarian cancer	0.000661	0.000661	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000659	0.000659	CcSEcCtD
Gadoversetamide—Fatigue—Docetaxel—ovarian cancer	0.000658	0.000658	CcSEcCtD
Gadoversetamide—Angiopathy—Epirubicin—ovarian cancer	0.000658	0.000658	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—ovarian cancer	0.000657	0.000657	CcSEcCtD
Gadoversetamide—Immune system disorder—Epirubicin—ovarian cancer	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000653	0.000653	CcSEcCtD
Gadoversetamide—Pain—Docetaxel—ovarian cancer	0.000653	0.000653	CcSEcCtD
Gadoversetamide—Constipation—Docetaxel—ovarian cancer	0.000653	0.000653	CcSEcCtD
Gadoversetamide—Chills—Epirubicin—ovarian cancer	0.00065	0.00065	CcSEcCtD
Gadoversetamide—Arrhythmia—Epirubicin—ovarian cancer	0.000647	0.000647	CcSEcCtD
Gadoversetamide—Asthenia—Paclitaxel—ovarian cancer	0.000646	0.000646	CcSEcCtD
Gadoversetamide—Pruritus—Paclitaxel—ovarian cancer	0.000637	0.000637	CcSEcCtD
Gadoversetamide—Mental disorder—Epirubicin—ovarian cancer	0.000635	0.000635	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—ovarian cancer	0.000634	0.000634	CcSEcCtD
Gadoversetamide—Malnutrition—Epirubicin—ovarian cancer	0.000631	0.000631	CcSEcCtD
Gadoversetamide—Erythema—Epirubicin—ovarian cancer	0.000631	0.000631	CcSEcCtD
Gadoversetamide—Feeling abnormal—Docetaxel—ovarian cancer	0.000629	0.000629	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—ovarian cancer	0.000627	0.000627	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—ovarian cancer	0.000625	0.000625	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000624	0.000624	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000622	0.000622	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—ovarian cancer	0.000622	0.000622	CcSEcCtD
Gadoversetamide—Flatulence—Epirubicin—ovarian cancer	0.000622	0.000622	CcSEcCtD
Gadoversetamide—Tension—Epirubicin—ovarian cancer	0.000619	0.000619	CcSEcCtD
Gadoversetamide—Dysgeusia—Epirubicin—ovarian cancer	0.000618	0.000618	CcSEcCtD
Gadoversetamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000616	0.000616	CcSEcCtD
Gadoversetamide—Nervousness—Epirubicin—ovarian cancer	0.000613	0.000613	CcSEcCtD
Gadoversetamide—Back pain—Epirubicin—ovarian cancer	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—ovarian cancer	0.000608	0.000608	CcSEcCtD
Gadoversetamide—Muscle spasms—Epirubicin—ovarian cancer	0.000607	0.000607	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—ovarian cancer	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
Gadoversetamide—Abdominal pain—Docetaxel—ovarian cancer	0.000603	0.000603	CcSEcCtD
Gadoversetamide—Body temperature increased—Docetaxel—ovarian cancer	0.000603	0.000603	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—ovarian cancer	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—ovarian cancer	0.000599	0.000599	CcSEcCtD
Gadoversetamide—Dizziness—Paclitaxel—ovarian cancer	0.000596	0.000596	CcSEcCtD
Gadoversetamide—Vision blurred—Epirubicin—ovarian cancer	0.000595	0.000595	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—ovarian cancer	0.000587	0.000587	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000585	0.000585	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—ovarian cancer	0.000584	0.000584	CcSEcCtD
Gadoversetamide—Agitation—Epirubicin—ovarian cancer	0.00058	0.00058	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—ovarian cancer	0.000575	0.000575	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—ovarian cancer	0.000573	0.000573	CcSEcCtD
Gadoversetamide—Vomiting—Paclitaxel—ovarian cancer	0.000573	0.000573	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—ovarian cancer	0.000572	0.000572	CcSEcCtD
Gadoversetamide—Malaise—Epirubicin—ovarian cancer	0.000569	0.000569	CcSEcCtD
Gadoversetamide—Rash—Paclitaxel—ovarian cancer	0.000568	0.000568	CcSEcCtD
Gadoversetamide—Dermatitis—Paclitaxel—ovarian cancer	0.000567	0.000567	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—ovarian cancer	0.000567	0.000567	CcSEcCtD
Gadoversetamide—Vertigo—Epirubicin—ovarian cancer	0.000567	0.000567	CcSEcCtD
Gadoversetamide—Syncope—Epirubicin—ovarian cancer	0.000566	0.000566	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—ovarian cancer	0.000565	0.000565	CcSEcCtD
Gadoversetamide—Headache—Paclitaxel—ovarian cancer	0.000564	0.000564	CcSEcCtD
Gadoversetamide—Hypersensitivity—Docetaxel—ovarian cancer	0.000562	0.000562	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—ovarian cancer	0.000561	0.000561	CcSEcCtD
Gadoversetamide—Palpitations—Epirubicin—ovarian cancer	0.000558	0.000558	CcSEcCtD
Gadoversetamide—Loss of consciousness—Epirubicin—ovarian cancer	0.000554	0.000554	CcSEcCtD
Gadoversetamide—Cough—Epirubicin—ovarian cancer	0.000551	0.000551	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—ovarian cancer	0.00055	0.00055	CcSEcCtD
Gadoversetamide—Asthenia—Docetaxel—ovarian cancer	0.000548	0.000548	CcSEcCtD
Gadoversetamide—Convulsion—Epirubicin—ovarian cancer	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Hypertension—Epirubicin—ovarian cancer	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000542	0.000542	CcSEcCtD
Gadoversetamide—Pruritus—Docetaxel—ovarian cancer	0.00054	0.00054	CcSEcCtD
Gadoversetamide—Chest pain—Epirubicin—ovarian cancer	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Arthralgia—Epirubicin—ovarian cancer	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Myalgia—Epirubicin—ovarian cancer	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—ovarian cancer	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Anxiety—Epirubicin—ovarian cancer	0.000535	0.000535	CcSEcCtD
Gadoversetamide—Nausea—Paclitaxel—ovarian cancer	0.000535	0.000535	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Discomfort—Epirubicin—ovarian cancer	0.000531	0.000531	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—ovarian cancer	0.000526	0.000526	CcSEcCtD
Gadoversetamide—Dry mouth—Epirubicin—ovarian cancer	0.000525	0.000525	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—ovarian cancer	0.000524	0.000524	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—ovarian cancer	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Diarrhoea—Docetaxel—ovarian cancer	0.000522	0.000522	CcSEcCtD
Gadoversetamide—Confusional state—Epirubicin—ovarian cancer	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—ovarian cancer	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Gadoversetamide—Oedema—Epirubicin—ovarian cancer	0.000515	0.000515	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—ovarian cancer	0.000513	0.000513	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—ovarian cancer	0.000509	0.000509	CcSEcCtD
Gadoversetamide—Shock—Epirubicin—ovarian cancer	0.000507	0.000507	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—ovarian cancer	0.000506	0.000506	CcSEcCtD
Gadoversetamide—Nervous system disorder—Epirubicin—ovarian cancer	0.000505	0.000505	CcSEcCtD
Gadoversetamide—Dizziness—Docetaxel—ovarian cancer	0.000505	0.000505	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—ovarian cancer	0.000504	0.000504	CcSEcCtD
Gadoversetamide—Tachycardia—Epirubicin—ovarian cancer	0.000503	0.000503	CcSEcCtD
Gadoversetamide—Skin disorder—Epirubicin—ovarian cancer	0.0005	0.0005	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000498	0.000498	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—ovarian cancer	0.000497	0.000497	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—ovarian cancer	0.000497	0.000497	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—ovarian cancer	0.000497	0.000497	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—ovarian cancer	0.000495	0.000495	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000494	0.000494	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Gadoversetamide—Anorexia—Epirubicin—ovarian cancer	0.000491	0.000491	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—ovarian cancer	0.000486	0.000486	CcSEcCtD
Gadoversetamide—Vomiting—Docetaxel—ovarian cancer	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Rash—Docetaxel—ovarian cancer	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Hypotension—Epirubicin—ovarian cancer	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Dermatitis—Docetaxel—ovarian cancer	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—ovarian cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Headache—Docetaxel—ovarian cancer	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000476	0.000476	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—ovarian cancer	0.000476	0.000476	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000469	0.000469	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—ovarian cancer	0.000469	0.000469	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000467	0.000467	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000466	0.000466	CcSEcCtD
Gadoversetamide—Insomnia—Epirubicin—ovarian cancer	0.000466	0.000466	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—ovarian cancer	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—ovarian cancer	0.000463	0.000463	CcSEcCtD
Gadoversetamide—Paraesthesia—Epirubicin—ovarian cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000461	0.000461	CcSEcCtD
Gadoversetamide—Dyspnoea—Epirubicin—ovarian cancer	0.000459	0.000459	CcSEcCtD
Gadoversetamide—Somnolence—Epirubicin—ovarian cancer	0.000458	0.000458	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—ovarian cancer	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Nausea—Docetaxel—ovarian cancer	0.000453	0.000453	CcSEcCtD
Gadoversetamide—Dyspepsia—Epirubicin—ovarian cancer	0.000453	0.000453	CcSEcCtD
Gadoversetamide—Decreased appetite—Epirubicin—ovarian cancer	0.000448	0.000448	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—ovarian cancer	0.000445	0.000445	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000445	0.000445	CcSEcCtD
Gadoversetamide—Fatigue—Epirubicin—ovarian cancer	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Pain—Epirubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Constipation—Epirubicin—ovarian cancer	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000434	0.000434	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—ovarian cancer	0.000431	0.000431	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—ovarian cancer	0.000428	0.000428	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—ovarian cancer	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Feeling abnormal—Epirubicin—ovarian cancer	0.000424	0.000424	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—ovarian cancer	0.000424	0.000424	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000421	0.000421	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000419	0.000419	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—ovarian cancer	0.000414	0.000414	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000411	0.000411	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—ovarian cancer	0.000411	0.000411	CcSEcCtD
Gadoversetamide—Urticaria—Epirubicin—ovarian cancer	0.000409	0.000409	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Gadoversetamide—Abdominal pain—Epirubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Gadoversetamide—Body temperature increased—Epirubicin—ovarian cancer	0.000407	0.000407	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000393	0.000393	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00039	0.00039	CcSEcCtD
Gadoversetamide—Hypersensitivity—Epirubicin—ovarian cancer	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—ovarian cancer	0.000378	0.000378	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—ovarian cancer	0.000377	0.000377	CcSEcCtD
Gadoversetamide—Asthenia—Epirubicin—ovarian cancer	0.000369	0.000369	CcSEcCtD
Gadoversetamide—Pruritus—Epirubicin—ovarian cancer	0.000364	0.000364	CcSEcCtD
Gadoversetamide—Diarrhoea—Epirubicin—ovarian cancer	0.000352	0.000352	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—ovarian cancer	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—ovarian cancer	0.000342	0.000342	CcSEcCtD
Gadoversetamide—Dizziness—Epirubicin—ovarian cancer	0.00034	0.00034	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—ovarian cancer	0.000337	0.000337	CcSEcCtD
Gadoversetamide—Vomiting—Epirubicin—ovarian cancer	0.000327	0.000327	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—ovarian cancer	0.000326	0.000326	CcSEcCtD
Gadoversetamide—Rash—Epirubicin—ovarian cancer	0.000325	0.000325	CcSEcCtD
Gadoversetamide—Dermatitis—Epirubicin—ovarian cancer	0.000324	0.000324	CcSEcCtD
Gadoversetamide—Headache—Epirubicin—ovarian cancer	0.000323	0.000323	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—ovarian cancer	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Nausea—Epirubicin—ovarian cancer	0.000306	0.000306	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—ovarian cancer	0.000303	0.000303	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—ovarian cancer	0.0003	0.0003	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—ovarian cancer	0.0003	0.0003	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—ovarian cancer	0.000298	0.000298	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—ovarian cancer	0.000283	0.000283	CcSEcCtD
